MGC Pharmaceuticals Ltd
ASX:MXC
MGC Pharmaceuticals Ltd
ASX:MXC
Price:
0.415
AUD
Market Cap:
AU$18.2m
Income Statement
Earnings Waterfall
MGC Pharmaceuticals Ltd
MGC Pharmaceuticals Ltd
Income Statement
MGC Pharmaceuticals Ltd
MGC Pharmaceuticals Ltd
Currency: AUD
| Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
+50%
|
0
+33%
|
0
+25%
|
0
-20%
|
0
-50%
|
0
N/A
|
0
-50%
|
0
N/A
|
0
N/A
|
0
+240%
|
0
+141%
|
0
+252%
|
0
+46%
|
0
-7%
|
0
+112%
|
1
+53%
|
1
-12%
|
2
+227%
|
2
-3%
|
1
-50%
|
3
+187%
|
5
+61%
|
5
-2%
|
5
+2%
|
3
-30%
|
1
-61%
|
|
| Gross Profit | |||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+171%
|
0
-1%
|
0
-16%
|
0
+391%
|
1
+56%
|
0
-48%
|
0
-1%
|
0
-41%
|
0
+49%
|
1
+321%
|
2
+44%
|
2
+4%
|
2
+48%
|
1
-47%
|
0
-77%
|
|
| Operating Income | |||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(7)
|
(7)
|
(7)
|
(8)
|
(9)
|
(13)
|
(11)
|
(11)
|
(13)
|
(15)
|
(16)
|
(18)
|
(17)
|
(16)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(5)
|
(7)
|
(7)
|
(5)
|
(5)
|
(5)
|
(7)
|
(6)
|
(5)
|
(7)
|
(10)
|
(12)
|
(15)
|
(14)
|
(14)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
0
|
(4)
|
0
|
(3)
|
0
|
(2)
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(1)
|
0
|
|
| Other Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
(0)
|
0
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(6)
|
(1)
|
(5)
|
(2)
|
(3)
|
0
|
(2)
|
|
| Operating Income |
(0)
N/A
|
(0)
+7%
|
(0)
+48%
|
(0)
+19%
|
(0)
-71%
|
(1)
-121%
|
(1)
-16%
|
(0)
+42%
|
(1)
-19%
|
(1)
-65%
|
(1)
-1%
|
(2)
-137%
|
(2)
-20%
|
(4)
-58%
|
(7)
-83%
|
(7)
-2%
|
(7)
+3%
|
(7)
-2%
|
(9)
-24%
|
(13)
-44%
|
(11)
+10%
|
(10)
+9%
|
(12)
-14%
|
(13)
-12%
|
(14)
-10%
|
(16)
-8%
|
(15)
+3%
|
(16)
-2%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(2)
|
(3)
|
(4)
|
(5)
|
(1)
|
(1)
|
(2)
|
(1)
|
|
| Non-Reccuring Items |
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
(3)
|
(4)
|
(4)
|
(2)
|
(2)
|
(6)
|
(2)
|
(0)
|
(2)
|
(5)
|
(5)
|
(0)
|
0
|
(0)
|
(5)
|
(8)
|
(5)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
-2%
|
(0)
+8%
|
(0)
+62%
|
(0)
-71%
|
(1)
-124%
|
(1)
-17%
|
(0)
+42%
|
(5)
-1 114%
|
(6)
-18%
|
(4)
+40%
|
(6)
-61%
|
(6)
-2%
|
(6)
+5%
|
(9)
-44%
|
(13)
-48%
|
(9)
+29%
|
(7)
+21%
|
(11)
-55%
|
(18)
-59%
|
(19)
-7%
|
(13)
+31%
|
(16)
-23%
|
(18)
-13%
|
(21)
-15%
|
(24)
-17%
|
(21)
+13%
|
(17)
+19%
|
|
| Net Income | |||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(5)
|
(6)
|
(4)
|
(6)
|
(6)
|
(6)
|
(9)
|
(13)
|
(9)
|
(7)
|
(11)
|
(18)
|
(19)
|
(13)
|
(16)
|
(18)
|
(21)
|
(24)
|
(21)
|
(17)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(3)
N/A
|
0
N/A
|
2
+349%
|
(0)
N/A
|
(0)
-71%
|
(1)
-124%
|
(1)
-17%
|
(0)
+42%
|
(5)
-1 114%
|
(6)
-18%
|
(4)
+40%
|
(6)
-61%
|
(6)
-1%
|
(6)
+7%
|
(8)
-43%
|
(12)
-49%
|
(8)
+32%
|
(7)
+17%
|
(9)
-25%
|
(15)
-72%
|
(19)
-31%
|
(14)
+29%
|
(16)
-15%
|
(18)
-11%
|
(20)
-16%
|
(23)
-15%
|
(21)
+11%
|
(17)
+18%
|
|
| EPS (Diluted) |
-0.32
N/A
|
0.03
N/A
|
0.12
+300%
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
0
N/A
|
-0.03
N/A
|
-0.03
N/A
|
-0.01
+67%
|
-0.02
-100%
|
-0.01
+50%
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-8.33
-83 200%
|
-0.01
+100%
|
-7.93
-79 200%
|
-9
-13%
|
-7.07
+21%
|
-0.73
+90%
|
|
Switch to:
Switch to:
See Also
Discover More
